Literature DB >> 18074936

Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.

G Franceschini1, D Terribile, S Magno, C Fabbri, P F D'Alba, F Chiesa, A Di Leone, R Masetti.   

Abstract

Locally advanced breast cancer represents a wide variety of neoplasms and constitutes approximately 10%-20% of the newly diagnosed breast cancers. These cancers may have widely different clinical and biological characteristics. According to the American Joint Committee on Cancer (AJCC) staging system, all of stage III disease is considered locally advanced. The clinical treatment of locally advanced breast cancer is complex and should be tailored to the individual patient. In this paper we discuss the options of management of locally advanced breast cancer, focusing on a multidisciplinary approach through a combined-modality care involving surgery, radiotherapy and systemic therapy.

Entities:  

Mesh:

Year:  2007        PMID: 18074936

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient.

Authors:  G Franceschini; A Martin Sanchez; A Di Leone; S Magno; F Moschella; C Accetta; R Masetti
Journal:  G Chir       Date:  2015 Jul-Aug

2.  Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts.

Authors:  Christine Staudigl; Michaela Bartova; Mohamed Salama; Giorgi Dzagnidze; Zsuzsanna Bago-Horvath; Kamil Pohlodek; Christian F Singer; Muy-Kheng M Tea
Journal:  Tumour Biol       Date:  2014-12-28

3.  Effect of neoadjuvant chemotherapy (NAC) on programmed cell death ligand (PD-L1) in patients of carcinoma breast: A prospective study in Indian tertiary care setting.

Authors:  Vipul Srivastava; B R Akshay; Sweety Kumari; Ram Niwas Meena; Rahul Khanna
Journal:  J Family Med Prim Care       Date:  2020-08-25

4.  MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer.

Authors:  Jian-Ping Cheng; Ying Yan; Xiang-Yi Wang; Yuan-Li Lu; Yan-Hua Yuan; Jun Jia; Jun Ren
Journal:  Chin J Cancer       Date:  2011-01

5.  Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.

Authors:  Mariel Garcia-Chagollan; Irma Edith Carranza-Torres; Pilar Carranza-Rosales; Nancy Elena Guzmán-Delgado; Humberto Ramírez-Montoya; María Guadalupe Martínez-Silva; Ignacio Mariscal-Ramirez; Carlos Alfredo Barrón-Gallardo; Ana Laura Pereira-Suárez; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

6.  The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.

Authors:  Fatma Umit Malya; Huseyin Kadioglu; Huseyin Kazim Bektasoglu; Zuhal Gucin; Seyma Yildiz; Mehmet Guzel; Ezgi Basak Erdogan; Serap Yucel; Yeliz Emine Ersoy
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.